| Literature DB >> 22860004 |
Qinghua Nie1, Erin E Sandford, Xiquan Zhang, Lisa K Nolan, Susan J Lamont.
Abstract
Avian pathogenic Escherichia coli (APEC) leads to economic losses in poultry production and is also a threat to human health. The goal of this study was to characterize the chicken spleen transcriptome and to identify candidate genes for response and resistance to APEC infection using Solexa sequencing. We obtained 14422935, 14104324, and 14954692 Solexa read pairs for non-challenged (NC), challenged-mild pathology (MD), and challenged-severe pathology (SV), respectively. A total of 148197 contigs and 98461 unigenes were assembled, of which 134949 contigs and 91890 unigenes match the chicken genome. In total, 12272 annotated unigenes take part in biological processes (11664), cellular components (11927), and molecular functions (11963). Summing three specific contrasts, 13650 significantly differentially expressed unigenes were found in NC Vs. MD (6844), NC Vs. SV (7764), and MD Vs. SV (2320). Some unigenes (e.g. CD148, CD45 and LCK) were involved in crucial pathways, such as the T cell receptor (TCR) signaling pathway and microbial metabolism in diverse environments. This study facilitates understanding of the genetic architecture of the chicken spleen transcriptome, and has identified candidate genes for host response to APEC infection.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22860004 PMCID: PMC3409229 DOI: 10.1371/journal.pone.0041645
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Schematic of Illumina EST analysis.
It includes sample preparation, cDNA library construction and Illumina sequencing, data analysis including assemble, blast, GO annotation, gene expression analysis, etc.
Summary of draft reads of three libraries by Illumina deep sequencing.
| Groups | PE library size (bp) | Read pairs | Read length (bp) | Total residues (bp) |
| NC | 200 | 14,422,935 | 81 | 2,336,515,470 |
| MD | 200 | 14,104,324 | 81 | 2,284,900,488 |
| SV | 200 | 14,954,692 | 81 | 2,422,660,104 |
| Total | 200 | 43,481,951 | 81 | 7,044,076,062 |
NC, MD, and SV are three groups of non-challenged, challenged-mild pathology, and challenged-severe pathology, respectively.
Figure 2Sequence length distribution of contigs assembled from Illumina reads.
All Illumina reads of non-challenged (NC), challenged-mild pathology (MD) and challenged-severe pathology (SV) were used in assembly analysis which gave rise to 148197 contigs. The horizontal and vertical axes show the size of contigs and log number contigs, respectively.
Distribution of contigs and unigenes in chicken genome.
| Chromosomes | Counts ofcontigs | Counts ofunigenes | Genomesize |
| 1 | 20,456 | 14,336 | 200,994,015 |
| 2 | 14,092 | 10,142 | 154,873,767 |
| 3 | 11,719 | 8,254 | 113,657,789 |
| 4 | 11,219 | 7,407 | 94,230,402 |
| 5 | 9,245 | 6,303 | 62,238,931 |
| 6 | 5,098 | 3,517 | 37,400,442 |
| 7 | 5,329 | 3,534 | 38,384,769 |
| 8 | 5,071 | 3,344 | 30,671,729 |
| 9 | 4,427 | 2,901 | 25,554,352 |
| 10 | 4,084 | 2,777 | 22,556,432 |
| 11 | 3,204 | 2,243 | 21,928,095 |
| 12 | 3,446 | 2,344 | 20,536,687 |
| 13 | 3,335 | 2,268 | 18,911,934 |
| 14 | 4,016 | 2,598 | 15,819,469 |
| 15 | 4,105 | 2,488 | 12,968,165 |
| 16 | 222 | 116 | 432,983 |
| 17 | 2,996 | 1,875 | 11,182,526 |
| 18 | 4,498 | 1,785 | 10,925,261 |
| 19 | 3,225 | 2,066 | 9,939,723 |
| 20 | 3,204 | 2,126 | 13,986,235 |
| 21 | 2,054 | 1,397 | 6,959,642 |
| 22 | 834 | 539 | 3,936,574 |
| 23 | 1,885 | 1,257 | 6,042,217 |
| 24 | 1,363 | 932 | 6,400,109 |
| 25 | 547 | 334 | 2,031,799 |
| 26 | 1,903 | 1,197 | 5,102,438 |
| 27 | 1,516 | 955 | 4,841,970 |
| 28 | 1,761 | 1,164 | 4,512,026 |
| Z | 7,304 | 5,334 | 74,602,320 |
| MT | 13 | 10 | 16,775 |
| Total | 142,171 | 95,543 |
|
Genome size for each chromosome is based on the released chicken whole genome sequence in either NCBI (ftp://ftp.ncbi.nih.gov/genomes/Gallus_gallus/) or ENSEMBL database (ftp://ftp.ensembl.org/pub/release-63/fasta/gallus_gallus/dna/).
Because some contigs and unigenes have multiple locations in genome, only 134,949 contigs and 91,890 unigenes match with chicken genome.
Figure 3Functional classification of chicken transcriptome.
(A) GO: Biological process. (B) Cellular component. (C) GO: Molecular function. Each transcript or gene generally has multiple functions.
Figure 4Differentially expressed genes that are unique or shared among three groups of NC, MD and SV.
NC Vs. MD refers to the comparison between non-challenged (NC) and challenged-mild pathology (MD) groups. NC Vs. SV refers to the comparison between NC and challenged-severe pathology (SV) groups. MD Vs. SV refers to the comparison between MD and SV groups. Numbers in each section of the figure indicate the numbers of differently expressed genes in the indicatedcomparison.
Involvement of differentially expressed genes in predicted pathways by KEGG enrichment analysis.
| No. | Pathways | #unigenes | upval | dpval | enrichment |
| 1 | Metabolic pathways | 514 (252) | 1.39E−60 | 1 | yes |
| 2 | Purine metabolism | 418 (199) | 1.04E−46 | 1 | yes |
| 3 | Thiamine metabolism | 359 (181) | 9.06E−47 | 1 | yes |
| 4 | T cell receptor signaling pathway | 105 (38) | 1.80E−06 | 0.999999 | yes |
| 5 | Biosynthesis of secondary metabolites | 98 (53) | 2.15E−17 | 1 | yes |
| 6 | Lysine degradation | 75 (42) | 1.48E−13 | 1 | yes |
| 7 | Drug metabolism - other enzymes | 71 (35) | 6.33E−10 | 1 | yes |
| 8 | Tropane, piperidine and pyridine alkaloid biosynthesis | 56 (30) | 8.95E−10 | 1 | yes |
| 9 | Microbial metabolism in diverse environments | 29 (22) | 2.61E−11 | 1 | yes |
| 10 | Oxidative phosphorylation | 28 (21) | 2.32E−11 | 1 | yes |
| 11 | Biosynthesis of phenylpropanoids | 19 (13) | 1.09E−06 | 1 | yes |
| 12 | Metabolism of xenobiotics by cytochrome | 18 (9) | 0.001988018 | 0.999624 | yes |
| 13 | Drug metabolism - cytochrome | 18 (9) | 0.001988018 | 0.999624 | yes |
| 14 | Phenylalanine metabolism | 17 (14) | 4.38E−08 | 1 | yes |
| 15 | beta-Alanine metabolism | 15 (8) | 0.00116723 | 0.999828 | yes |
| 16 | Methane metabolism | 13 (9) | 5.11E−05 | 0.999996 | yes |
| 17 | Glycolysis/Gluconeogenesis | 12 (10) | 2.44E−06 | 1 | yes |
| 18 | Phenylpropanoid biosynthesis | 12 (9) | 2.22E−05 | 0.999999 | yes |
| 19 | Histidine metabolism | 6 (6) | 0.00010714 | 1 | yes |
| 20 | Tyrosine metabolism | 6 (6) | 0.00010714 | 1 | yes |
Refer to the numbers of involved total unigenes and differently expressed unigenes (in bracket).
Differentially expressed genes involved in the T cell receptor (TCR) signaling pathway.
| No. | Gene | Description |
| 1 | MAPKSP1 | PREDICTED: mitogen-activated protein kinase scaffold protein 1-like isoform 1#PREDICTED: similar to dual adaptor of phosphotyrosine and 3-phosphoinositides#PREDICTED: hypothetical protein#PREDICTED: dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide-like#PREDICTED: ragulator complex protein LAMTOR3-like |
| 2 | PTPN13 | PREDICTED: tyrosine-protein phosphatase non-receptor type 13-like |
| 3 | PTPRF | PREDICTED: receptor-type tyrosine-protein phosphatase F-like, partial |
| 4 | PPP1CC | serine/threonine-protein phosphatase PP1-gamma catalytic subunit#mCG129661, isoform CRA_c |
| 5 | BTAF1; Dusp11 | PREDICTED: similar to Dual specificity phosphatase 11 (RNA/RNP complex 1-interacting)#PREDICTED: TATA-binding protein-associated factor 172-like |
| 6 | PP2C-epsilon | PREDICTED: similar to protein phosphatase 2C epsilon |
| 7 | PTPN23 | LOC100170608 protein#PREDICTED: tyrosine-protein phosphatase non-receptor type 23-like |
| 8 | PTPN14 | PREDICTED: similar to protein tyrosine phosphatase, non-receptor type 14 isoform 2#protein tyrosine phosphatase, non-receptor type 14, isoform CRA_c#PREDICTED: similar to protein tyrosine phosphatase, non-receptor type 14 isoform 1 |
| 9 | SBF1 | PREDICTED: similar to tyrosine kinase#myotubularin-related protein 5 isoform 1 |
| 10 | PTPN11 | PREDICTED: tyrosine-protein phosphatase non-receptor type 11-like |
| 11 | KIAA0371 | PREDICTED: similar to Cysteine rich protein 2#PREDICTED: similar to KIAA0371 |
| 12 | EYA3 | PREDICTED: eyes absent homolog 3-like isoform 2#PREDICTED: similar to eyes absent 3 |
| 13 | CD148 | receptor-type tyrosine-protein phosphatase eta |
| 14 | PTPRQ | PREDICTED: phosphotidylinositol phosphatase PTPRQ-like |
| 15 | CD45; PTPRC | receptor-type tyrosine-protein phosphatase C |
| 16 | p70; STS1 | PREDICTED: similar to KIAA1959 protein |
| 17 | N/A | PREDICTED: hypothetical protein |
| 18 | Dusp22 | PREDICTED: similar to RP23-217J3.1 |
| 19 | Ptprr | PREDICTED: receptor-type tyrosine-protein phosphatase R-like |
| 20 | Ppp2r2a | serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform#hypothetical protein PANDA_002366#PREDICTED: serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B delta isoform-like#PREDICTED: alpha isoform of regulatory subunit B55, protein phosphatase 2 isoform 1#unnamed protein product#PREDICTED: protein phosphatase PP2A 55 kDa regulatory subunit isoform 1 |
| 21 | PPM1A | PREDICTED: protein phosphatase 1A (formerly 2C), magnesium-dependent, alpha isoform#PREDICTED: similar to protein phosphatase 2C alpha; PP2Calpha |
| 22 | Dusp11 | PREDICTED: similar to Dual specificity phosphatase 11 (RNA/RNP complex 1-interacting)#PREDICTED: RNA/RNP complex-1-interacting phosphatase-like |
| 23 | PTPRQ | PREDICTED: phosphotidylinositol phosphatase PTPRQ-like |
| 24 | PTPN6 | tyrosine-protein phosphatase non-receptor type 6 |
| 25 | PTPN1; PTP1B | tyrosine-protein phosphatase non-receptor type 1#PREDICTED: similar to PDE4DIP protein#protein tyrosine phosphatase#PREDICTED: similar to phosphodiesterase 4D interacting protein#PREDICTED: tyrosine-protein phosphatase non-receptor type 1-like |
| 26 | SSH-2 | PREDICTED: similar to slingshot-2L#PREDICTED: protein phosphatase Slingshot homolog 2-like |
| 27 | PTPN22 | PREDICTED: similar to Tyrosine-protein phosphatase non-receptor type 22 (Hematopoietic cell protein-tyrosine phosphatase 70Z-PEP) (Lymphoid phosphatase) (LyP) |
| 28 | LCK | LCK_CHICKRecName: Full = Proto-oncogene tyrosine-protein kinase LCK; AltName: Full = Protein-tyrosine kinase C-TKL; AltName: Full = p56tk1 |
| 29 | CTDNEP1 | CTD nuclear envelope phosphatase 1 |
| 30 | Ppm1k | PREDICTED: similar to Protein phosphatase 1K (PP2C domain containing)#Hyperion protein, 419 kD isoform#PREDICTED: protein phosphatase 1K, mitochondrial-like |
| 31 | Ppm1f | PREDICTED: similar to Protein phosphatase 1F (PP2C domain containing) |
| 32 | PTPN5; Step | PREDICTED: tyrosine-protein phosphatase non-receptor type 5-like |
| 33 | RAD9A;RAD9 | cell cycle checkpoint control protein RAD9A#putative protein phosphatase 1 catalytic subunit alpha |
| 34 | PTPRB; PTPB | PREDICTED: similar to Protein tyrosine phosphatase, receptor type, B |
| 35 | PTPN21 | PREDICTED: tyrosine-protein phosphatase non-receptor type 21-like |
| 36 | MTMR8 | myotubularin-related protein 8 |
| 37 | SSH1 | PREDICTED: similar to Slingshot homolog 1 (Drosophila) |
| 38 | PIX1 | PREDICTED: similar to partner of PIX 1 |
Genes are named based on NCBI gene database (http://www.ncbi.nlm.nih.gov/gene/). N/A means not available.
Comparison of gene expression that differs significantly among NC, MD and SV for CD148, CD45 and LCK.
| Gene | Expression value | NC vs. MD | NC vs. SV | MD V = vs. SV | |||||
| NC | MD | SV | Fold change | q value | Fold change | q value | Fold change | q value | |
| CD148 | 955 | 991 | 1191 | −0.2113 | 0.0128 | −0.4345 | 1.45E−10 | −0.2232 | 0.0091 |
| CD45 | 19572 | 17645 | 17329 | −0.0084 | 0.7551 | 0.0597 | 0.000912 | 0.0681 | 0.0006 |
| LCK | 1465 | 1035 | 837 | 0.3434 | 1.63E-07 | 0.6917 | 1.67E−27 | 0.3484 | 1.76E-05 |
The expression value is based on the obtained reads within the specific gene in the three groups of [non-challenged (NC), challenged-mild pathology (MD), and challenged-severe pathology (SV)].
Refers to normalized fold changes.
The q-value was calculated according to Benjamini et al. (1995) [38].
Figure 5Comparison of CD148, CD45 and LCK expression among NC, MD and SV.
(A) CD148. (B) CD45. (C) LCK. NC, MD and SV stand for the groups of non-challenged, challenged-mild pathology, and challenged-severe pathology, respectively. The normalized expression value of NC is set as 1, by which the value of MD and SV are determined. *, ** and *** represent q-value significance at the level of 0.05, 0.01 and 0.001, respectively.